Work

Supplementary Figure S4 from Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 4. Related to Fig. 2, 3 and Supplementary Fig. 5-7. 68-year-old female with bilateral lung metastases and multiple mediastinal lymph node metastasis was treated with chemo-immunotherapy (carboplatin, pemetrexed, and pembrolizumab). PD-L1 expression in the pre-treatment tumor specimen was 2%. The patient had stable disease for 621 days with overall survival > 3 years. A Contrast-enhanced cross-sectional imaging obtained at prior to and during treatment. B Expression of CX3CR1 in peripheral blood CD8 T cells (left) and the CX3CR1 score (right) at different time points as indicated.

DOI: 10.1158/2767-9764.22358070.v1

Authors: Eihab Abdelfatah, Mark D. Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher Attwood, Junko Matsuzaki, Brahm H. Segal, Grace K. Dy, Fumito Ito

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361197713

Cites:

Cited by:

Related to: 10